RecruitingNot ApplicableNCT06030011

Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations


Sponsor

The University of Texas Health Science Center, Houston

Enrollment

270 participants

Start Date

Jun 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The PI and the research team developed the New York University (NYU) Electronic Patient Visit Assessment (ePVA) for head and neck cancer (HNC) as a patient-reported outcome measure (PRO) for the early detection of uncontrolled symptoms. The ePVA is digital patient-reported symptom monitoring system, providing actionable information at point-of-care that enables clinicians to provide real-time interventions. The study aims to advance the science of cancer care delivery by testing the effectiveness of the ePVA as a digital patient-reported monitoring system for patients with HNC in real-world settings and identify implementation strategies that optimize the effectiveness of the ePVA in diverse rural and urban settings. The study hypothesis is that participants assigned to the ePVA arm will have better swallowing, taste and smell, and social function than participants assigned to usual care arm at 4 weeks after completing radiation therapy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether an electronic symptom-tracking tool called the ePVA (Electronic Patient Visit Assessment) helps patients with head and neck cancer communicate their symptoms better to their care team during radiation therapy. The tool collects self-reported symptoms and shares them digitally with clinicians. The study is testing this across both rural and urban settings to understand access and usability. **You may be eligible if (as a patient)...** - You have been diagnosed with head and neck cancer - You are currently receiving radiation therapy (with or without chemotherapy) with curative intent - You speak English or Spanish **You may be eligible if (as a clinician)...** - You are a healthcare provider (doctor, nurse, dentist, social worker, nutritionist, speech therapist) caring for head and neck cancer patients at a participating hospital **You may NOT be eligible if...** - You have a medical condition that limits your ability to give consent or complete questionnaires Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALNYU Electronic Patient Visit Assessment (ePVA)

The NYU Electronic Patient Visit Assessment (ePVA) for head and neck cancer is a digital patient-reported symptom monitoring system, providing actionable information at point-of-care that enables clinicians to provide real-time interventions. Patients access the ePVA through a web link and complete the survey questions within 10 minutes on digital devices (e.g., smart phones, laptops, or digital devices provided by the clinic).

BEHAVIORALUsual Care

Usual care encompasses pre-treatment, on treatment, and post-treatment care. Pre-treatment care includes education of patients on the treatment plan. On-treatment care includes daily monitoring by a nurse in the radiation therapy (RT) department, weekly on-treatment visits with the RT nurse practitioner and radiation oncologist, and weekly visits with medical oncology nurse practitioners and medical oncologists for patients receiving RT plus chemotherapy. Post-treatment care includes follow-up visits with HNC clinicians (i.e., surgeon, medical oncologist, oral maxillofacial surgeons, and radiation oncologist) to assess the patient's cancer status and identify the patient's acute and long-term symptoms. The clinician's decisions on radiologic exams and referrals to appropriate specialist services, including dental care, are based on the patient's cancer status and symptoms.


Locations(5)

University of Kansas Cancer Center

Kansas City, Kansas, United States

NYU Meyers College of Nursing

New York, New York, United States

NYU Langone Perlmutter Cancer Center

New York, New York, United States

Fox Chase Cancer Center

Philadelphia, Pennsylvania, United States

UTHealth Houston Cizik School of Nursing

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06030011


Related Trials